FIELD: medicine, pharmaceutics.
SUBSTANCE: invention involves a granule of epidermal growth factor and a sulphur antioxidant specified in a group consisting of methionine and K2S2O7. The granules possess a target solution profile.
EFFECT: there are presented a method for preparing the above granules, a capsule, and using the above granule in treating ulcerative colitis.
20 cl, 7 ex, 8 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE RECEPTOR 5 (MGLU5) ANTAGONISTS | 2011 |
|
RU2602955C2 |
SOLID ENTERIC ORAL DOSAGE FORM OF PROINSULIN C-PEPTIDE (VERSIONS) AND METHOD FOR PREPARING IT (VERSIONS) | 2013 |
|
RU2522897C1 |
PANTOPRAZOLE COMPOUNDS CONSISTING OF SET OF PARTICLES | 2004 |
|
RU2361574C2 |
CONTROLLED RELEASE SOLID DRUG | 2006 |
|
RU2467740C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
SOLID COMPOSITION FOR DELIVERY | 2018 |
|
RU2812928C2 |
PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION | 2010 |
|
RU2604861C2 |
THE PHARMACEUTICAL COMPOSITIONS CONTAINING pH - DEPENDENT MEDICAL PRODUCT, THE pH MODIFIER AND THE SLOWING DOWN AGENT | 2006 |
|
RU2442574C2 |
PHARMACEUTICAL MEDICINAL FORMS FOR ORAL INTAKE CONTAINING INHIBITOR OF PROTON PUMP AND AGENT FOR NONSTEROID ANTI-INFLAMMATORY THERAPY | 1996 |
|
RU2158138C2 |
Authors
Dates
2015-02-10—Published
2011-02-10—Filed